Published in Proc Biol Sci on January 07, 2015
Combined SYBR Green real-time polymerase chain reaction and microarray method for the simultaneous determination of human papillomavirus loads and genotypes. Obstet Gynecol Sci (2016) 0.75
Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa. PLoS One (2017) 0.75
Mechanistic mathematical models: An underused platform for HPV research. Papillomavirus Res (2017) 0.75
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
Superspreading and the effect of individual variation on disease emergence. Nature (2005) 14.01
The web of human sexual contacts. Nature (2001) 9.14
Coevolution of hosts and parasites. Parasitology (1982) 7.55
Imperfect vaccines and the evolution of pathogen virulence. Nature (2001) 4.74
Concurrent partnerships as a driver of the HIV Epidemic in sub-Saharan Africa? The evidence is limited. AIDS Behav (2009) 4.06
The papillomavirus life cycle. J Clin Virol (2005) 3.41
Viruses' life history: towards a mechanistic basis of a trade-off between survival and reproduction among phages. PLoS Biol (2006) 3.09
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.91
Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol (2006) 2.81
The biology and life-cycle of human papillomaviruses. Vaccine (2012) 2.53
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine (2008) 2.48
Evaluating human papillomavirus vaccination programs. Emerg Infect Dis (2004) 2.47
Immune responses to human papillomavirus. Vaccine (2006) 2.37
How will HPV vaccines affect cervical cancer? Nat Rev Cancer (2006) 2.23
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med (2006) 2.10
Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host. Vet J (2005) 1.99
In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted? Proc Natl Acad Sci U S A (2002) 1.82
Using time-structured data to estimate evolutionary rates of double-stranded DNA viruses. Mol Biol Evol (2010) 1.80
Immunobiology of HPV and HPV vaccines. Gynecol Oncol (2008) 1.66
Measures of sexual partnerships: lengths, gaps, overlaps, and sexually transmitted infection. Sex Transm Dis (2006) 1.61
Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol (2001) 1.61
Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol (2012) 1.58
Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine (2012) 1.58
Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol (2006) 1.53
Inference of R(0) and transmission heterogeneity from the size distribution of stuttering chains. PLoS Comput Biol (2013) 1.49
HPV - immune response to infection and vaccination. Infect Agent Cancer (2010) 1.48
Human papillomavirus vaccines--immune responses. Vaccine (2012) 1.40
Models of CD8+ responses: 1. What is the antigen-independent proliferation program. J Theor Biol (2003) 1.38
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis (2010) 1.37
Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology (2004) 1.37
Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol (2008) 1.35
Modeling host-parasite coevolution: a nested approach based on mechanistic models. J Theor Biol (2002) 1.35
Sexual network structure and sexually transmitted disease prevention: a modeling perspective. Sex Transm Dis (2000) 1.33
The effect of pair formation and variable infectivity on the spread of an infection without recovery. Math Biosci (1998) 1.32
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Evaluating the importance of within- and between-host selection pressures on the evolution of chronic pathogens. Theor Popul Biol (2007) 1.17
Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine (2006) 1.16
Papillomavirus DNA replication - from initiation to genomic instability. Virology (2009) 1.15
Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection. J Virol Methods (2007) 1.11
Multiple evolutionary mechanisms drive papillomavirus diversification. Mol Biol Evol (2007) 1.10
Quantifying the phylodynamic forces driving papillomavirus evolution. Mol Biol Evol (2011) 1.08
Trade-offs and the evolution of virulence of microparasites: do details matter? Theor Popul Biol (2003) 1.06
Vaccination and reduced cohort duration can drive virulence evolution: Marek's disease virus and industrialized agriculture. Evolution (2012) 1.06
Prophylactic HPV vaccines: new interventions for cancer control. Vaccine (2008) 1.01
Sex work during the 2010 FIFA World Cup: results from a three-wave cross-sectional survey. PLoS One (2011) 0.99
What limits the evolutionary emergence of pathogens? Philos Trans R Soc Lond B Biol Sci (2013) 0.99
Evidences of parasite evolution after vaccination. Vaccine (2008) 0.97
Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus. J Virol (2013) 0.96
Transmission-recovery trade-offs to study parasite evolution. Am Nat (2008) 0.94
Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. J Infect Dis (2012) 0.91
Evolutionary ecology of human papillomavirus: trade-offs, coexistence, and origins of high-risk and low-risk types. J Infect Dis (2011) 0.89
Recombination-dependent oligomerization of human papillomavirus genomes upon transient DNA replication. J Virol (2013) 0.89
Age- and gender-specific estimates of partnership formation and dissolution rates in the Seattle sex survey. Ann Epidemiol (2010) 0.89
Introducing the outbreak threshold in epidemiology. PLoS Pathog (2013) 0.88
Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine. J Clin Virol (2000) 0.86
Vaccination and the evolutionary ecology of human papillomavirus. Vaccine (2008) 0.83
When do sexual partnerships need to be accounted for in transmission models of human papillomavirus? Int J Environ Res Public Health (2010) 0.83
Natural HPV immunity and vaccination strategies. J Clin Virol (2000) 0.82